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 3 
Abstract: The clustered regularly interspaced short palindromic repeat (CRISPR) systems have 4 
a wide variety of applications besides precise genome editing. In particular, the CRISPR/dCas9 5 
system can be used to control specific gene expression by CRISPR activation (CRISPRa) or 6 
interference (CRISPRi). However, the safety concerns associated with viral vectors and the 7 
possible off-target issues of systemic administration remain huge concerns to be safe delivery 8 
methods for CRISPR/Cas9 systems. In this study, a layer-by-layer (LbL) self-assembling peptide 9 
(SAP) coating on nanofibers is developed to mediate localized delivery of CRISPR/dCas9 10 
systems. Specifically, an amphiphilic negatively charged SAP
-
 is first coated onto PCL 11 
nanofibers through strong hydrophobic interactions, and the pDNA complexes and positively 12 
charged SAP
+
-RGD are then absorbed via electrostatic interactions. The SAP-coated scaffolds 13 
facilitate efficient loading and sustained release of the pDNA complexes, while enhancing cell 14 
adhesion and proliferation. As a proof of concept, the scaffolds are used to activate GDNF 15 
expression in mammalian cells, and the secreted GDNF subsequently promotes neurite 16 
outgrowth of rat neurons. These promising results suggest that the LbL self-assembling peptide 17 
coated nanofibers can be a new route to establish a bioactive interface, which provides a simple 18 
and efficient platform for the delivery of CRISPR/dCas9 systems for regenerative medicine. 19 
 20 




































































1. Introduction 1 
The clustered regularly interspaced short palindromic repeat (CRISPR) systems have 2 
evolved as powerful tools for precise genome editing in diverse biological applications [1, 2]. 3 
These systems use a single guide RNA (sgRNA) to direct the Cas9 nuclease to the target gene, 4 
resulting in gene deletion, insertion, and mutation [1-4]. Additionally, a transcriptional regulator 5 
can be fused to the dead Cas9 (dCas9), in which the two catalytic domains of Cas9 are 6 
inactivated and thus have no cleavage activity [5]. This allows the CRISPR/dCas9 system to be 7 
used to activate or interfere with specific gene expression, named CRISPR activation (CRISPRa) 8 
and CRISPR interference (CRISPRi) respectively [6, 7]. Unfortunately, apart from these 9 
promising features, challenges remained for the CRISPR/Cas9 system to be translated for 10 
clinical applications. Although viral vectors like adeno-associated virus (AAV) have shown great 11 
efficacy in CRISPR/Cas9 system delivery, the immunogenic response and long-term expression 12 
of viral vectors are still the main concerns [8, 9]. Meanwhile, the uptake of the vectors by 13 
undesired tissue or organ, especially during systemic administration, may cause off-target issues, 14 
which may lead to tumorigenic or other deleterious events. To overcome these limitations, we 15 
sought to develop an effective non-viral approach to deliver CRISPR/Cas9 components in a 16 
sustained and localized fashion, which is often required for tissue regeneration. 17 
Polycaprolactone (PCL) is widely used for the fabrication of tissue engineering scaffolds by 18 
various techniques, including electrospinning and 3D printing [10, 11], owing to its 19 
machinability, structural stability, biocompatibility and biodegradability. However, the intrinsic 20 
hydrophobicity and absence of reactive ligands on PCL lead to ineffective cell adhesion and 21 
biomolecules immobilization, which hinders the further development of the scaffolds for tissue 22 




































































surface modification. Lately, inspired by mussel adhesion chemistry, many groups, including 1 
ourselves, have demonstrated the easy-to-operate polydopamine coating strategy on PCL 2 
scaffolds, which could significantly enhance cell-substrate interactions and biomolecule 3 
immobilizations [12-19]. Such bioadhesive coating allowed effective scaffold-mediated delivery 4 
of Cas9-sgRNA ribonucleoprotein to cells [18]. However, although the mechanism is still 5 
unclear, the special surface chemistry of polydopamine has been reported to be not favorable to 6 
some sensitive cells [18]. Therefore, we aim to develop a novel coating strategy that is more 7 
cytocompatible and allows scaffold surface-mediated delivery of CRISPR/dCas9 system for 8 
CRISPRa. We delivered the systems through dCas9 plasmid DNA (pDNA) in this study due to 9 
its low cost, flexibility, and stability, which is useful for us to test on the new coating platform 10 
[20]. As a proof of concept, scaffold-mediated gene activation of Glial cell derived neurotrophic 11 
factor (GDNF) would be an interesting strategy to stimulate nerve regeneration as it delivers both 12 
topographical and biochemical cues to guide cellular and tissue regrowth. 13 
In this study, we successfully fashioned a layer-by-layer (LbL) self-assembling peptide 14 
(SAP) coating on nanofibers that can mediate localized delivery of CRISPR/dCas9 system to 15 
promote neural regeneration. We first established an easy-to-operate approach for the bioactive 16 
functionalization of PCL nanofibers by SAP. These SAP-coated nanofibers exhibited good 17 
affinity towards pDNA/PEIpro complexes and hence could facilitate the efficient loading and 18 
sustained release of such complexes. Owing to the incorporation of RGD peptides, the scaffolds 19 
could also support cell adhesion and proliferation. Other than the RGD, our SAP-based scaffold 20 
design also allows facile incorporation of other bioactive peptides, thereby offering a superb 21 
platform for the investigation of cell-substrate interactions. Furthermore, due to these promising 22 




































































GDNF expression in mammalian cells, and the secreted GDNF could subsequently promote 1 
neurite outgrowth. We believe that the strategy reported in this work opens up a new route to 2 
establish a bioactive interface and a simple and efficient platform for the delivery of 3 
CRISPR/dCas9 systems for regenerative medicine. 4 
 5 
2. Materials and methods 6 
2.1. Materials  7 
Polycaprolactone (average Mw = 80000), 2,2,2-trifluoroethanol (TFE), heparin sodium salt and 8 
Triton-X 100 were purchased from Sigma-Aldrich (USA). Sodium hydroxide was purchased 9 
from Merck (Germany). All chemicals were used as received without further purification. The 10 
self-assembling peptide, SAP
-
 (FEFEFEFE) and SAP
+
-RGD (FKFKFKFKGGRGDSP), were 11 
synthesized by Genscript (USA) and characterized by HPLC and ESI-MS (Supplementary 12 
Methods Section 1. Characterization of SAP). Paraformaldehyde (PFA, 4%) was purchased from 13 
Santa Cruz Biotechnology. PEIpro transfection reagent was purchased from Polyplus (USA). 14 
Plasmid pSpCas9(BB)-2A-GFP (PX458) (“Cas9-GFP”; 9288 bp) was a gift from Feng Zhang 15 
(Addgene plasmid #48138) (Fig. S3) [21], and SP-dCas9-VPR (“dCas9-VPR”; 11,319 bp) was a 16 
gift from George Church (Addgene plasmid #63798) (Fig. S4) [22]. sgRNA expression vector 17 
(3028 bp) harboring a U6 promoter positioned upstream of the customized sgRNA sequence was 18 
obtained from Genscript (USA) and confirmed by DNA sequencing. The sequences of sgRNA 19 
are shown in Table S1. Fibroblast growth factor-2 was purchased from Peprotech (USA). M-20 
MLV Reverse Transcriptase was obtained from Promega (USA). Human GDNF Duoset ELISA 21 




































































from MirusBio (USA). SingleShot SYBR Green One-Step Kit and iTaq Universal SYBR Green 1 
One-Step Kit were purchased from Bio-Rad (USA). hMSCs were purchased from Lonza 2 
(Switzerland). All other cell culture reagents, Quant-iT PicoGreen dsDNA assay kit, Click-iT 3 
EdU cell proliferation assay kit and SYBR Select Master Mix were purchased from 4 
ThermoFisher (USA).  5 
 6 
2.2. Fabrication of LbL SAP-coated nanofibers 7 
Electrospun nanofibers were fabricated according to our previous report [18]. In brief, small 8 
strips of PCL films with thickness of 20 m were adhered onto coverslips (Ø 18 mm) to create a 9 
1 cm
2
 area, and the coverslips were then placed on a rotation wheel (2400 rpm) for the collection 10 
of electrospun nanofibers. The PCL solution (14 wt% in TFE) was loaded into a syringe and 11 
dispensed at a fixed rate (1.0 mL h
-1
) by a syringe pump. Voltages of +8 kV and −4 kV were 12 
then applied to the blunt needle tip and the rotating collector, respectively. The distance between 13 
spinneret and collector was set as 22 cm. The obtained electrospun fibers were sterilized by UV 14 





-RGD peptide powders were dissolved in sterilized 0.1 mм NaOH solution (1%, 16 
w/v) and 0.1 mм HCl (1%, w/v), respectively, and sonicated for 30 min prior to use. To get the 17 
LbL assembled scaffolds, 50 L of SAP
-
 solution (0.2%, w/v) was firstly dripped onto the PCL 18 
nanofibers to cover the 1 cm
2
 scaffold area. After incubation at 37 °C for 2 h, the scaffolds were 19 
rinsed with DI H2O to remove uncombined peptides. 4 L of PEIpro (1 mg/mL) were diluted in 20 




































































at room temperature for 15 min and then placed onto the scaffolds to allow adsorption at 37 °C 1 
for 1 h. The unbonded complexes were removed by washing with DI H2O, and 50 L of SAP
+
-2 
RGD solution (0.2%, w/v) was then added onto the scaffolds. After incubation at 37 °C for 2 h, 3 
the scaffolds were rinsed again with DI H2O to remove uncombined peptides. To investigate the 4 
sequential alternation of surface charges during LbL coating, the PCL nanoparticles (Ø ~ 400 nm) 5 
were coated with the same protocol and the zeta-potential was measured by Malvern Nano-ZS 6 
Zeta Sizer after each step. The experiment was repeated 3 times. 7 
 8 
2.3. SEM characterization of scaffolds 9 
The lyophilized samples were sputter-coated with platinum at 10 mA for 100 s, and then the 10 
surface morphology of the scaffolds was observed under a scanning electron microscope (SEM, 11 
JOEL, JSM-6390LA) at a 10-kV accelerating voltage. The average fiber diameters were 12 
measured by ImageJ (NIH) with at least 100 fibers per sample.  13 
 14 
2.4. Water contact angle measurements 15 







-RGD scaffolds were measured by the sessile drop 17 
method using a contact angle analyzer (Kruss DSA 25). The droplet volume was set as 2 L. 18 





































































2.5. FT-IR measurements 1 
To evaluate changes in chemical bond characteristics of the PCL scaffolds before and after SAP 2 
coating, FTIR was carried out by using a Fourier-transform infrared spectrometer (PerkinElmer 3 
Spectrum One). Spectra were acquired in the 400 – 4000 cm
-1
. The samples were subjected to 4 
flash freezing and lyophilization prior to the measurement. 5 
 6 
2.6. Characterizations of complex loading and release 7 
To visualize the distribution of pDNA/PEIpro complexes on the scaffolds, pDNA was tagged 8 
with MFP488 using Label IT nucleic acid labeling kit as per the manufacturer’s instructions. The 9 
MFP488-tagged pDNA was then complexed with PEIpro and adsorbed onto the scaffolds 10 
according to the protocol mentioned above. The scaffolds were then visualized under an 11 
epifluorescence microscope (Leica DMi8). 12 
To test the loading efficiency of the pDNA/PEIpro complexes on the scaffolds, the rinsate 13 
during coating processes was collected carefully. After de-complexion from the pDNA/PEIpro 14 
complexes using heparin sodium salt (1:1 v/v, 20 g mL
-1
), the amount of pDNA in the rinsate 15 
was determined using the Quant-iT PicoGreen dsDNA assay kit according to manufacturer’s 16 
protocol. The experimental loading efficiencies were computed using the following equation: 17 
Loading efficiency (%) = 
        
  




































































where mt is the total mass of pDNA used for loading, mu is the mass of unbound pDNA (pDNA 1 
remained in the complex coating solution) and ml the mass of pDNA loss during the coating of 2 
SAP
+
-RGD (pDNA released into the SAP
+
-RGD coating solution).  3 
Subsequently, the scaffolds were incubated with 1 mL of PBS at 37 °C. While culture media 4 
better mimics the cell culture condition, the other components in the culture media or serum 5 
protein may affect the DNA assay reactions and plate reader readings. At each time point, 1 mL 6 
of PBS was collected from each sample and replaced with an equal volume of fresh PBS. The 7 
supernatant was then used to measure the amount of pDNA by the same protocol mentioned 8 
above. 9 
 10 
2.7. Cell culture  11 
U2OS cells were a generous gift from Professor Wenting Zhao at Nanyang Technological 12 
University. The U2OS cells and hMSCs were cultured in high-glucose DMEM with GlutaMAX, 13 
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. The medium change 14 
was performed every 2-3 days. hNPCs were generated from induced-pluripotent stem cells as 15 
described previously [23]. The cells were cultured on poly-L-ornithine and laminin-coated 16 
culture dishes in maintenance medium, which consisted of DMEM/F12 supplemented with 1% 17 
glutaMAX, 1% N2 supplement, 2% B27 supplement, 1% penicillin/streptomycin and 20 ng mL
-1
 18 
FGF2. All the cells were cultured in a humidified incubator at 37 °C and 5% CO2. Passage 6 19 





































































2.8. Cell adhesion, proliferation and scaffold-mediated local transfection  1 
To assess the effects of different surface coatings on cell adhesion, U2OS and hMSCs were 2 
seeded at a density of 10,000 cells cm
-2
, while hNPCs were seeded at a density of 50,000 cells 3 
cm
-2
. To assess the effects of the SAP-coating on cell proliferation, the cell-seeded scaffolds 4 
were incubated with 10 mм EdU for 24 h before being fixed with 4% PFA. The scaffolds were 5 
permeabilized with 0.25% Triton-X then stained with the Click-iT reaction cocktail and Hoechst 6 
33342. In each group, over 10 images from at least 3 scaffolds were taken at 20×, and at least 7 
200 cells were quantified. The number of nuclei and EdU labelled nuclei were counted. For 8 
scaffold-mediated local transfection experiments, the Cas9-GFP plasmid was used, in which the 9 
2A-GFP was fused to Cas9 to allow the detection of Cas9 expression in the transfected cells, and 10 
the U2OS cells were also seeded at a density of 10,000 cells cm
-2
. After incubation at 37 °C for 11 
48 h, the cells were fixed with 4% PFA solution for 10 min and then permeabilized in 0.25% 12 
Triton-X 100 in PBS for 15 min at room temperature. For morphology studies, the cytoskeleton 13 
was stained with Alexa Fluor 555 phalloidin or Alexa Fluor 488 phalloidin, and nuclei were 14 
stained with DAPI. Fluorescent images were acquired with an epifluorescence microscope (Leica 15 
DMi8) and analyzed using Image J (NIH). In each group, over 10 images from at least 3 16 
scaffolds were taken using a 20× objective, and at least 50 cells were quantified. The circularity 17 




where A is the area occupied by cell and P is the perimeter of cell. Higher circularity means less 20 
spreading. In addition, the total cell number was counted by DAPI, while the GFP
+
 cells were 21 





































































2.9. Subcutaneous implantation  2 
To assess the biocompatibility of the SAP-coated scaffolds in vivo, 1 × 1 cm PCL fiber scaffolds 3 
with thickness of 94 ± 4.7 µm were prepared with or without SAP coating according to the 4 
procedure mentioned. All experimental procedures that involved animals were performed in 5 
accordance with the Nanyang Technological University’s Institutional Animal Care and Use 6 
Committee, (IACUC, NTU) guidelines. Sprague-Dawley rats (8 weeks, 200-250g) were 7 
anesthetized with isoflurane before shaving their backs. Thereafter, subcutaneous pockets were 8 
created using surgical scissors after 1.2 cm incisions were made beside the spinal column. 9 
Following that, the scaffolds were inserted into the subcutaneous pockets such that each animal 10 
received both plain and SAP-coated scaffolds. The wounds were then closed with suture and the 11 
animals were observed for 5 days. After 5 days, animals were sacrificed and the tissues enclosing 12 
scaffolds were harvested and fixed in 4% PFA overnight. Thereafter, the scaffolds were 13 
dehydrated, embedded in paraffin and sectioned to obtain 5 µm thick sections. The sections were 14 
then stained with Haematoxylin and Eosin (H&E) and imaged with ZEISS Axio Scan.Z1 using a 15 
20× objective. The images were then analyzed by an experimenter blinded to experimental 16 
groups. Semi-quantitative evaluation was performed on the scaffold biocompatibility based on 17 
fibrotic tissue formation, presence of macrophages (rounded morphology) at the boundary of the 18 
scaffold, and fibroblasts (elongated morphology) infiltration into the scaffold; using a scoring 19 
system, +: minimal, ++: some, +++: moderate, ++++: significant (n = 4 rats). To further evaluate 20 
inflammatory response towards the scaffolds, the number of macrophages and neutrophils in the 21 
scaffolds were counted. A total of 18 evenly distributed ROIs (50 µm × 50 µm) were assessed 22 





































































2.10. Bolus transfection experiments 2 
A preliminary test has been performed with different transfection reagents, including 3 
Lipofectamine 3k, L-PEI, PEIpro, and JetOPTIMUS (Fig. S14). PEIpro demonstrated one of the 4 
highest transfection efficiency and acceptable toxicity and hence was used for the subsequent 5 
experiments. For gene activation experiments, U2OS cells were seeded onto 24-well plates at a 6 
density of 20,000 cells per well. Twenty-four hours after plating, cells were transfected with 7 
Cas9-GFP plasmids or a 1:1 mass ratio of dCas9 plasmid:sgRNA plasmids. A total plasmid mass 8 
of 0.5 g per well was transfected using 0.5 L per well of PEIpro reagent. For synergy 9 
experiments, the amount of total sgRNA was kept constant and the mass ratio of each sgRNA 10 
was 1:1 or 1:1:1. The cells were harvested 2 d after transfection, and gene expression analysis 11 
was performed.  12 
 13 
2.11. Scaffold-mediated gene activation in mammalian cells 14 
For exogenous gene-activation experiments, the dCas9 expression plasmids and sgRNA 15 
plasmids were co-delivered with a mass ratio of 1:1, and the sub-mass ratio of each sgRNAs was 16 
1:1:1. U2OS cells were seeded onto the scaffolds at a density of 10,000 cells cm
-2
 in 200 µL 17 
culture medium. The medium was sufficient to cover the 1 cm
2 
scaffold area. Three experiments 18 
were performed. Gene activation was verified by gene expression analysis (Section 2.12). The 19 
amount of GDNF secreted by the U2OS cells on the scaffolds was quantified by ELISA. 20 




































































medium for 3 days, and the collected medium was then stored at -80 °C for subsequent assays 1 
(Section 2.13). To test the bioactivity of the secreted GDNF, medium was collected after 3 days 2 
of culture without medium replacement. Thereafter, the collected medium was added to the 3 
cortical neurons and DRG explant cultures as conditioned medium (Section 2.14).  4 
 5 
2.12. Gene expression analysis  6 
After 2 days of culture, cells seeded on the 24-well plates were lysed by TRIzol reagent, and 7 
RNA was extracted according to the manufacturer’s instructions. The RNA concentration was 8 
determined by the NsD-1000 spectrophotometer (NanoDrop Technologies), and 500 ng of RNA 9 
from each sample were reverse transcribed into cDNA using M-MLV Reverse Transcriptase. 10 
Real-time PCR was performed on the StepOnePlus system (Applied Biosystems) using SYBR 11 
Select Master Mix. The sequences of the primers are listed in Table S2 and GAPDH was used as 12 
the housekeeping gene. The primers were checked to have similar amplification efficiency. The 13 
PCR parameter was 10 min at 95 °C, followed by 15 s at 95 °C and 1 min at 60 °C for 40 cycles. 14 
The relative gene expression was calculated using the ΔΔCT method, where the fold difference 15 
was calculated using the expression       . For cells that were seeded on the scaffolds, the cells 16 
were lysed by SingleShot SYBR Green One-Step Kit and PCR was performed with iTaq 17 
Universal SYBR Green One-Step Kit according to the manufacturer’s instructions. 18 
 19 




































































The amount of secreted GDNF in the medium was quantified using the media obtained in 1 
Section 2.11. Specifically, after the scaffolds were functionalized with SAP coatings and 2 
plasmids, U2OS cells were seeded onto the scaffolds at a density of 10,000 cells cm
-2 
in 200 µl 3 
medium. The medium was collected every 24 h and replaced with 200 µl fresh medium for three 4 
days. The collected medium was stored in -80 °C freezer until quantification and was measured 5 
by using a human GDNF ELISA kit following the manufacturer’ s instructions without dilution. 6 
In brief, 96-well microplate was coated with 100 µL/well of the Capture Antibody and incubated 7 
overnight at room temperature, followed by washing with wash buffer for three times. Thereafter, 8 
non-specific binding was blocked with Reagent Diluent at room temperature for 1 h prior to 9 
wash for three times. The samples and standards were then added into the coated wells (100 µL 10 
each) and incubated for 2 h at room temperature. The antigen was then incubated with 100 µL of 11 
Detection Antibody for 2 h, followed by the solution of Streptavidin-HRP A for 20 min in dark. 12 
The addition of Substrate Solution (100 µL each) started the color reaction which was stopped 20 13 
min later with 50 µL of Stop Solution. The optical density of each well was immediately 14 
measured at 450 nm with a reference wavelength at 570 nm. GDNF concentrations were 15 
determined from the regression line for the GDNF standard ranging from 31.3 to 500 pg/mL. 16 
Each sample represents one scaffold. Medium from three control and CRISPRa-GDNF scaffolds 17 
was measured. 18 
 19 
2.14. Cortical neurons and DRG explants culture  20 
To test for the bioactivity of the GDNF secreted by the U2OS cells on the functionalized 21 




































































outgrowth. The conditioned media was obtained by collecting the 200 µl culture media from 1 
U2OS cells cultured on the control or CRISPRa-GDNF scaffolds for 3 days as mentioned in 2 
Section 2.11. Cortical neurons were isolated from P1 Sprague-Dawley rat pup brain cortices by 3 
trypsin digestion at 37 °C for 15 min. After the suspension was passed through a 70 µm cell 4 
strainer, the dissociated cortical neurons were seeded on aligned nanofiber scaffolds at 30,000 5 
cells cm
-2 
in the conditioned medium at 37 °C [24]. DRG explants were harvested from P3 rat 6 
pups and all the meninges from the DRGs were taken off. Two DRG explants were seeded onto 7 
each aligned nanofiber scaffolds with 1 cm
2 
area. The cortical neurons and DRG explants were 8 
then cultured in the 200 µl of the collected conditioned medium (Section 2.11) at 37 °C. After 9 
cultured for 3 days, cortical neurons and DRG explants were fixed with 4% PFA at room 10 
temperature for 20 min. After washing in PBS for 3 times, cortical neurons and DRG explants 11 
were permeabilized with 0.3% Triton X-100 followed by blocking with 10% goat serum for 1 h 12 
at room temperature. Thereafter, the samples were incubated with mouse anti-βIII-Tubulin (Tuj-13 
1, 1:1000 dilution) overnight at 4 °C, followed by incubation in goat anti-mouse Alexa Fluor 555 14 
secondary antibody for 2 h at room temperature. Cell nuclei were counterstained with DAPI. 15 
Fluorescent images were acquired with an epifluorescence microscope (Leica DMi8) and 16 
analyzed using Image J (NIH). At least 5 scaffolds of each group were used in this experiment. 17 
For cortical neurons, 10 images were taken using a 20× objective for each scaffold and at least 18 
90 cells were quantified for each group. For each DRG, the ten longest neurites were measured 19 
and averaged to determine the average neurite outgrowth length for each sample. At least 5 DRG 20 
explants were analyzed from each group. 21 
 22 




































































All values were presented as mean ± standard deviation (S.D). Outlier analysis was performed to 1 
exclude significant outliers from the subsequent analyses. One-way ANOVA and Tukey’s post-2 
hoc tests were used for samples that passed the homogeneity test. Otherwise, Kruskal–Wallis and 3 
Mann – Whitney U test were used for pairwise analysis. Student’s t-test was used to compare 2 4 
independent samples. Tests were conducted with a 95% confidence interval (α = 0.05). 5 
 6 
3. Results 7 
3.1. Preparation and characterization of LbL coated PCL nanofibers 8 




-RGD) were synthesized by Fmoc solid-phase 9 
method. High-pressure liquid chromatography (HPLC) confirmed that the purity of the peptides 10 
was 97.8% and 99.2%, respectively, and the mass spectrometry results assured the correct 11 
molecular weight of these peptides (Fig. S1, S2). The PCL nanofibers were fabricated using an 12 
electrospinning technique, and the LbL coating was then performed based on the strategy as 13 
illustrated in Scheme 1. SAP
-
, the amphiphilic peptide bearing negative charges, was firstly 14 
coated onto the PCL scaffolds by dip-coating, resulting in the negative surface charge. 15 
Subsequently, the positively charged pDNA/PEIpro complexes and SAP
+
-RGD were coated. 16 
This assembly process can also take place on the surface of PCL nanoparticles and was 17 
confirmed by the sequential alternation of zeta-potential (Fig. S5). The strong hydrophobic 18 
interactions between the aromatic side chains of the -sheet SAP
-
 and the PCL molecules 19 
allowed the adsorption of SAP
- 
onto the hydrophobic PCL surface, while the established 20 
negatively charged surface further facilitated the adsorption of pDNA/PEIpro complexes and 21 
subsequently SAP
+





































































Scheme 1. Schematic illustration of the layer-by-layer coating of SAPs on PCL nanofibers.  2 
As shown in the SEM images of the scaffolds (Fig. 1a), the SAP coatings did not mask the 3 
underlying fiber morphology. Specifically, the average fiber diameter of the plain PCL scaffolds 4 













-RGD”) was 945 ± 103 nm and 958 ± 96 nm, 6 
respectively. This suggests that the SAP coatings did not significantly alter the topography of the 7 
aligned fibers. 8 
Surface wettability is one of the most important surface properties that affect the cellular 9 
response towards an implanted substrate, including cell attachment, spreading, and proliferation. 10 
The contact angles of PCL and PCL@SAP
-
 were 99.3 ± 3.0 ° and 35.3 ± 2.9 °, respectively. The 11 
significantly increased hydrophilicity suggests the successful coating of the negatively charged 12 
SAP
-
. Subsequently, the adsorption of the positively charged PEI complexes and then the coating 13 
of SAP
+




































































the SAP-coated PCL scaffolds did not change significantly after incubation in phosphate-1 
buffered saline (PBS) for at least 7 days (Fig. S6), indicating the good stability of SAP 2 
modification. Furthermore, we also characterized these scaffolds by comparing typical chemical 3 
bonds before and after SAP coating. Fourier transform infrared (FT-IR) spectroscopy 4 
measurements revealed plain PCL scaffolds exhibited the absorption peak at 1720 cm
-1
, which is 5 
indicative of the -C=O stretching vibration of PCL (Fig. S7). After SAP
-
 coating, two strong 6 
peaks at 3293 cm
−1
 and 1635 cm
−1
 were observed, and these were attributed to the -NH- 7 
stretching vibration and -NH2 bending vibration of SAP
-
, respectively. These findings 8 





































































Fig. 1. Characterization of SAP-coated scaffolds. a) SEM images and photographs of water 1 
contact angles of the SAP-coated scaffolds; scale bar = 10 m. b) Fiber diameters (n = 3) and c) 2 
water contact angles of the SAP-coated scaffolds (n =3); 
***
p < 0.001, “NS” indicates “no 3 
significance”.   4 
 5 
3.2. SAP-coated scaffolds mediated efficient loading and sustained release of pDNA/PEIpro 6 
complexes  7 
Polyethylenimine (PEI), a cationic polymer, is a widely used and cost-effective reagent for 8 
gene delivery. However, the N-propionyl groups in PEI molecules may reduce the number of 9 
protonatable nitrogen residues and hinder the nucleic acid condensation and endosomal escape. 10 
Therefore, the deacylated PEI, commercially known as PEIpro, was chosen for this work and 11 
shown to be superior for the mammalian cells [25]. As shown in Fig. S8, no significant 12 
difference was observed in the particle size and zeta potential of PEIpro/pDNA complexes with 13 
an increase in N/P ratio. Thus, the complexes of N/P = 8 with moderate positive charge (+8.4 ± 14 
1.1 mV) and relatively small size (37.78 ± 11.06 nm) were chosen for all subsequent 15 
experiments. To visualize the distribution of the pDNA/PEIpro complexes on the scaffolds, 16 
fluorescently-tagged pDNA, MFP488-pDNA, was used. As shown in Fig. 2a, a uniform 17 
distribution of MFP488-pDNA/PEIpro complexes could be identified on the aligned fiber 18 














-RGD scaffolds was 82.9 ± 2.4%, 97.2 ± 2.6%, and 21 




































































from the scaffolds that were incubated in PBS at 37 °C (Fig. 2c). As compared to the plain PCL 1 
scaffolds in which the pDNA/PEIpro complexes were loosely entrapped, the SAP-coated 2 
scaffolds exhibited significantly smaller initial burst release and slower subsequent release of the 3 
complexes. These SAP-coated scaffolds were capable of releasing pDNA/PEIpro continuously 4 




-RGD scaffolds demonstrated similar 5 
loading efficiency and release rate as that of the PCL@SAP
- 
scaffolds, indicating that the 6 
subsequent coating of SAP
+
-RGD did not significantly affect the loading and release profile of 7 
the complexes. It is believed that the electrostatic interactions between the negatively charged 8 
SAP
-
 and positively charged pDNA/PEIpro complexes may help to immobilize these complexes 9 
on the scaffolds and slow down the release. In contrast, the faster release of complexes from the 10 
plain PCL scaffolds may be due to the lack of such stabilizing mechanisms. Moreover, this 11 
platform constructed by electrostatic interactions is also capable of trapping other complexes, 12 
which include some of the commonly used RNA/Lipofectamine, protein/Lipofectamine, and 13 
pDNA/semiconducting polymer nanoparticles (SPNs) (Fig. S9). Hence, the platform is believed 14 




































































  1 
Fig. 2. Characterization of the loading and release profiles of the pDNA/PEIpro complexes. 2 




































































aligned fiber substrates. Scale bar = 100 m (Insert: 10 m). b) Loading efficiency of 1 
pDNA/PEIpro complexes on the scaffolds (n = 3). c) Cumulative release profile of 2 
pDNA/PEIpro complexes from scaffolds over 7 days (n = 5). 3 
 4 
3.3. SAP-coated scaffolds promoted cell adhesion and proliferation 5 
To better visualize the nanofibers and cell-substrate interactions, Rhodamine B was linked to 6 
the N-terminus of SAP
-
. We subsequently examined the effect of SAP coating on cell adhesion 7 
by seeding U2OS cells on the scaffolds. As shown in Fig. 3a, after 48 h of culture, only a limited 8 
number of cells were observed on the plain PCL scaffolds, while significantly more cells were 9 






-RGD scaffolds (Fig. 3b), indicating the 10 
improved cell affinity. Similarly, when the cells were cultured in the serum-free medium, the 11 
RGD-bearing scaffolds still demonstrated the best cell adhesion performance (Fig. 3c), 12 
suggesting that the cells bound directly to RGD instead of the serum proteins that were present in 13 
the culture medium. Other than U2OS, these SAP-coated scaffolds can also support the adhesion 14 
and spreading of numerous cells, such as human mesenchymal stem cells (hMSCs) and human 15 
neural progenitor cells (hNPCs) (Fig. S10). Besides, enhanced cell proliferation was also 16 




-RGD scaffolds (Fig. S11). When these SAP-coated 17 
scaffolds were subcutaneously implanted, they showed better biocompatibility and cell 18 





































































Fig. 3. SAP coating enhanced cell adhesion on the scaffolds. a) Representative fluorescent 2 
images of U2OS cells on different scaffolds; scale bar = 50 m. Average cell number per mm
2
 of 3 
U2OS cells after 48 h of culture on scaffolds in b) full medium and c) FBS-free medium for 2 4 
days, respectively (n = 3);
 *
p < 0.05, 
**
p < 0.01, 
***
p < 0.001. 5 
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To facilitate the characterization of positive transfection using the CRISPR system, the 1 
reporter gene, GFP, was fused to the Cas9 expression cassette [21], and the Cas9-GFP plasmids 2 




-RGD group 3 
demonstrated the greatest number of GFP-positive cells and the highest intensity of green 4 
fluorescence. In comparison, the PCL@SAP
-
 group showed a smaller number of GFP-positive 5 
cells, and the green fluorescence was seldom observed in the absence of SAP coating (“PCL”). 6 




-RGD yielded 54.6 GFP
+





 and plain PCL only led to 14.4 and 0.7 GFP
+
 cells per mm
2
, 8 





RGD scaffold was significantly higher than the others owing to the enhanced adhesion, this 10 
group still showed the best GFP
+
 percentage (16.1%) among the three groups (Fig. 4c), which is 11 
similar to the efficiency of the bolus transfection (18.2%). Furthermore, the gene delivery 12 
efficiency was dose-dependent (Fig. S13). Specifically, we found that 4 µg was the optimal 13 
amount of plasmid as we started to see toxicity and lower efficiency at 6 µg. We also attempted 14 
to assess the transfection efficiency of hNPCs, which are more difficult to be transfected, by 15 
seeding these cells on the scaffolds. Correspondingly, we were only able to achieve a much 16 
lower transfection efficiency of 9.3% by scaffold-mediated delivery and 11.3% by bolus delivery 17 




































































  1 
Fig. 4. SAP-coated scaffolds enhanced the efficiency of Cas9-GFP transfection in 2 
mammalian cells. a) Representative fluorescent images of U2OS cells on different scaffolds; 3 
scale bar = 50 m. Quantification of b) average number of Cas9-GFP
+
 cells per mm
2
 and c) 4 
transfection efficiency based on fluorescent images (n = 3); 
**
p < 0.01, 
***
p < 0.001, “NS” 5 





































































3.5. Scaffold-mediated CRISPRa system promoted endogenous gene-activation in mammalian 1 
cells  2 
Having established the ability of the SAP-coated scaffolds to facilitate localized gene 3 
transfection of mammalian cells, we next examined their specific performance in the delivery of 4 
the CRISPRa system and constructed a CRISPRa system targeting hGDNF gene (Fig. 5a). Here, 5 
we aimed to utilize GDNF as a proof of concept because the protein secreted is easily detected 6 
and quantified, making it a straightforward evaluation of CRISPRa system delivery. The 7 
sequences of sgRNAs reported in the literature were ligated into sgRNA expressing vectors and 8 
confirmed by DNA sequencing (Table S1, Fig. S15) [26]. We first evaluated the sgRNAs in 9 
U2OS cells via co-delivery of sgRNA and dCas9-VPR (i.e., dCas9 fused with a potent tripartite 10 
activator, VP64, p65AD and Rta [22]) expressing vectors by bolus transfection, and the 11 
treatment significantly increased the mRNA expression of GDNF (Fig. 5b). Meanwhile, it has 12 
been reported that multiple sgRNA-dCas9-VP64 complexes can bind to a single promoter, 13 
thereby acting synergistically and more efficiently [27]. This synergistic effect was also observed 14 
in our experiments and hence the cocktail of sgRNAs (sg01 + 02 + 03) was used in the 15 
experiments hereafter.  16 
Subsequently, these pDNA/PEIpro complexes of both sgRNAs and dCas9-VPR expressing 17 
vectors were loaded onto the SAP-coated scaffolds, and the U2OS cells were seeded and 18 
cultured on the scaffolds. Compared to the non-treated control group, scaffold-mediated 19 
transfection of CRISPRa-GDNF resulted in substantial upregulation of GDNF mRNA expression 20 
(Fig. 5c). In order to quantify the secretion of GDNF, ELISA was used for the assay of cell 21 
culture medium at preset time points. Although the concentration of GDNF in the medium did 22 




































































(Fig. 5d), and the cumulative amount of GDNF secreted in the CRISPRa-GDNF group was also 1 
higher than that in the control group (Fig. 5e). However, due to the fast proliferation rate, the 2 
cells covered near 90% area of the scaffolds after 72 h, and hence the monitoring of GDNF 3 
expression had to be terminated. These results indicated that the CRISPRa system could be 4 
loaded onto the scaffolds and delivered to recipient cells for gene engineering. 5 
 6 
Fig. 5. SAP-coated scaffolds mediated the delivery of CRISPR/dCas9 based gene activation 7 
(CRISPRa-GDNF) system to enhance GDNF mRNA and protein expressions. a) Schematic 8 
representation of the CRISPRa-GDNF system. b) Relative expression of GDNF mRNA in U2OS 9 
cells in which the individual or combinations of sgRNAs were co-delivered with dCas9-VPR (n 10 




































































different time points and e) cumulative GDNF protein expression over 3 days in U2OS cells 1 




-RGD scaffolds (n = 3); 
*
p < 0.05, 
**
p < 0.01. 2 
3.6. Scaffold-mediated CRISPRa-GDNF system promoted neurite outgrowth  3 
To further investigate the functional effect of the scaffold-mediated CRISPRa-GDNF 4 
system, the ideal experiment would have been a co-culture experiment of U2OS cells and 5 
neurons. However, the complexity of keeping both cells alive in the same medium was difficult. 6 
The U2OS cells had a high proliferative rate on the scaffolds and would compete for nutrients 7 
with the neurons, without adding more media and supplements that might mask the effect of the 8 
secreted GDNF. Therefore, we collected the media containing GDNF that were secreted by the 9 
U2OS cells seeded on the CRISPRa-functionalized scaffold after 3 days (i.e. conditioned 10 
medium), and tested for the bioactivity of the secreted GDNF using primary neurons. 11 
Specifically, we transferred the conditioned medium to rat cortical neurons and dorsal root 12 
ganglia (DRGs) explants that were cultured on the nanofiber scaffolds for another 3 days. Fig. 6a 13 
and b show the representative fluorescent images of cortical neurons and DRGs cultured in 14 
culture medium from control and CRISPRa-GDNF scaffolds, respectively, and the neurite 15 
outgrowth along the long axis of fibers could be observed. Quantitative analysis confirmed that 16 
the CRISPRa-GDNF conditioned medium significantly enhanced neurite outgrowth in both 17 





































































Fig. 6. Scaffold-mediated CRISPRa-GDNF system promoted neurite outgrowth. 2 
Representative fluorescent images of a) rat cortical neurons and b) DRG explants cultured in 3 
control culture medium and CRISPRa-GDNF conditioned medium, respectively. White arrows 4 
represent fiber directions while yellow arrows indicate neurites. Quantification of the c) neurite 5 
length for cortical neurons (at least 100 neurites from 5 scaffolds each group) and d) average 6 





p < 0.01. 8 
 9 
4. Discussion 10 
Biodegradable polymers, such as PCL, are widely used for the fabrication of tissue 11 




































































modification. Therefore, simple noncovalent binding are methods usually accompanied by a 1 
quick loss of the coating layers due to insufficient interfacial interactions. On the other hand, the 2 
chemical modifications typically involve complex, laborious, and environmentally unfriendly 3 
chemical synthesis. Utilizing the hydrophobicity of PCL, the SAP coating can alter the surface 4 
charge of PCL fiber scaffolds. This approach offers a high level of customization as different 5 
peptides can be designed and incorporated into the coating according to specific needs (eg: 6 
surfaces with a positive charge, negative charge, cell adhesive peptides, etc). These 7 
functionalized SAPs can be coated onto the fibers alone or as a cocktail, and the ratio of different 8 
peptides can be adjusted easily. Therefore, the SAP coating is easy-to-implement and sufficiently 9 
stable to perform more than one role (eg: immobilization of biomolecules on the surface and 10 
support specific cell adhesion).  11 
By altering the surface charge, the PCL@SAP
- 
group demonstrated improved cell adhesion 12 
as compared to plain PCL (Fig. 3), similar to the effect of gas-plasma treatment on cell culture 13 
dishes, which makes them more hydrophilic and negatively-charged [28]. We conjugated RGD 14 
to the SAP
+
 as the RGD peptide can be recognized by the integrin subsets and as such may 15 
further enhance cell adhesion and spreading (Fig. 3) [29]. Moreover, the SAP backbone can also 16 
be conjugated with other peptide sequences other than RGD, such as laminin-derived peptides 17 
(IKVAV, YIGSR), N-cadherin mimetic peptide (HAVDI), and Wnt mimetic ligand (MDGECL), 18 
thereby offering superb flexibility for various applications [30]. For example, the laminin-19 
derived peptides can be conjugated to enhance neuronal adhesion and neurite outgrowth for 20 
neural tissue engineering. Therefore, we herein demonstrate a convenient method for the surface 21 





































































In this study, the scaffolds were capable of delivering the CRISPR/dCas9 system in a non-1 
viral manner, which is safer as compared to virus-mediated delivery that raises biosafety 2 
concerns. While non-viral polyplexes usually cause some cytotoxicity issues, an optimized 3 
delivery method can keep the toxicity under an acceptable level. Here, the cells grew with a high 4 
proliferation rate and covered over 90% scaffold area within 3 days, suggesting that the cell 5 
viability was acceptable. Such fiber scaffolds also provide more localized and sustained delivery 6 
of the CRISPR/dCas9 system than existing methods. In particular, the scaffold-mediated delivery 7 
approach ensures localized availability of drugs, which may reduce systemic side effects that is 8 
often prominent in systemic delivery approaches. Previous in vivo studies showed that similar 9 
approaches with scaffold-mediated gene delivery platforms locally released the complexes into 10 
the tissues within 300 μm from the edge of the scaffolds [31, 32]. Published results showed that 11 
the complexes immobilized on the scaffolds were directly uptaken by the cells from the scaffold 12 
surface [14, 18].  Here, Cas9-GFP signals in cells were observed within two days, where the 13 
cumulative release was only less than 5%, suggesting that the cells also took up the complexes 14 
directly from the scaffold surface. Although there were some larger polyplex aggregates on the 15 
scaffold, cellular uptake was not affected as around 97.3 ± 2.4 % cells were found to contain the 16 
labelled polyplexes within the cell body (Fig. S16). Furthermore, the modified nanofiber 17 
scaffolds can also provide topographical cues for tissue regeneration. In addition to 18 
CRISPR/dCas9 system, the coating is expected to be able to immobilize other biomolecules such 19 
as nucleic acids (siRNA, miRNA, plasmids) and proteins on the scaffold surfaces. 20 
In addition to the adsorption of CRISPR complexes on the SAP coated nanofibers, the 21 
enhanced cellular uptake of the complexes can also be attributed to the increased rate of cell 22 




































































proliferation during which the cell membranes undergo disruption and reconstruction [33]. Here, 1 




-RGD scaffold (Fig. S8), 2 
thereby possibly leading to the enhanced uptake of pDNA/PEIpro complexes. However, we did 3 
not achieve desirable transfection efficiency with hNPCs, a more realistic model, even by bolus 4 
delivery (Fig. S14). One major limitation of this platform is that the transfection efficiency may 5 
be affected by the effectiveness and efficiency of the delivery vehicles. Currently, low 6 
transfection efficiency is a common problem when transfecting the difficult-to-transfect primary 7 
cells, such as hNPCs, hMSCs and dermal fibroblasts [34, 35]. Although PEIpro was shortlisted 8 
as the most efficient commercially available transfection reagent through our initial optimization 9 
studies (Fig. S14), substituting PEIpro with a better-designed delivery vehicle may further 10 
improve the gene delivery efficiency of the scaffold to the hNPCs and neural cells in general. In 11 
addition, ribonucleoprotein may be a better format than pDNA in terms of CRISPR complex 12 
delivery due to less off-target effects and higher efficiency. As delivery of CRISPR complexes to 13 
primary neural cells, particularly post-mitotic neurons, may be challenging, a combination of the 14 
improved format (such as ribonucleoprotein) and delivery vehicle will be needed to achieve 15 
better results. Furthermore, a comprehensive in vivo evaluation of both transfection and gene 16 
activation for tissue regeneration will be needed for future pre-clinical studies. 17 
In this study, we only targeted a single gene (GDNF) as a proof of concept. By delivering 18 
CRISPRa systems through SAP-coated nanofibers, GDNF expression was activated and hence 19 
leading to the production of bioactive GDNF by cells, as demonstrated by the neurite outgrowth 20 
assays. While the main objective of this study is to evaluate the ability of the coating to deliver 21 
CRISPRa systems, the level of secreted GDNF (1.0×10
-3
 pg/cell/24h) is comparable to the 22 








































































effective in stimulating neurite outgrowth [36-40]. GDNF has already been well-established to 1 
enhance neurite outgrowth of rat DRG explants and cortical neurons. Hence, we did not include 2 
the GDNF-containing media as a positive control to save resources. In the literature, GDNF 3 
added at a concentration range of 1 to 100 ng/ml induced 1.5 to 7-folds increase in neurite length 4 
of the rat DRG in a dose-dependent manner [41-44]. Similarly, neurite length of rat cortical 5 
neurons increased 1.2 to 3-folds in the presence of 0.1 to 100 ng/ml GDNF in a dose-dependent 6 
manner [45-47]. The increase in neurite length of DRG and cortical neurons in our experiment 7 
were about 1.5-folds and 2-folds of the control respectively, which are within the range of the 8 
published results. A small amount of GDNF as little as 70 pg/ml could stimulate neurite 9 
outgrowth of spinal neurons [48]. 10 
In addition, the CRISPRa system is also capable of targeting multiple genes, requiring only 11 
additional sgRNAs. Future works may extend the application of the CRISPRa systems-loaded 12 
platform to relevant primary cells, such as glia and meningeal cells, which could be ideal targets 13 
in vivo to secrete GDNF locally to enhance nerve regeneration. This ability of selective gene 14 
upregulation provides a promising strategy to direct stem or progenitor cell differentiation for 15 
regenerative medicine applications [49]. For example, these scaffolds are expected to be capable 16 
of localized delivery of CRISPR/dCas9 to direct neuronal differentiation of stem cells through 17 
the activation of transcription factors, which will contribute to neural regeneration as well [50, 18 
51]. Besides the CRISPRa system, this scaffold-mediated CRISPR delivery system is also 19 
suitable for CRISPR knockout (CRISPRko) and CRISPRi systems when the corresponding 20 





































































5. Conclusion 1 
In summary, we synthesized two amphiphilic SAPs with opposite net charges, SAP
-
 and 2 
SAP
+
-RGD. The SAP was first coated onto PCL nanofibers through strong hydrophobic 3 
interactions, and the pDNA/PEIpro complexes and SAP
+
-RGD were then easily absorbed via 4 
electrostatic interactions. The SAP-coated scaffolds facilitated efficient loading and sustained 5 
release of the pDNA complexes, while similar amount of pDNA complexes were completely 6 
released from plain PCL scaffolds within 7 days. Meanwhile, the SAP coating effectively 7 
enhanced cell adhesion and proliferation, even in the absence of serum proteins (p < 0.0001). 8 
Therefore, these scaffolds were utilized for the localized delivery of the CRISPR/dCas9 system, 9 
which activated GDNF expression in mammalian cells and produced GDNF (1.0×10
-3
 10 
pg/cell/24h). The secreted GDNF retained its bioactivity and promoted neurite outgrowth, as 11 
evidenced by the twice longer neurites than the non-treated groups. All these promising results 12 
indicate that LbL SAP-coated nanofibers provide a useful tool for non-viral genome editing. 13 
Together with the continuously developing CRISPR techniques, such scaffolds demonstrate 14 
great potential in tissue regeneration. 15 
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